CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 23, 2020
January 20, 2021
d270daab-b0d8-413c-9870-899b1c8f31af
Related Documents
CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs
Guidance DocumentOctober 6, 2021Center for Veterinary Medicine
CVM GFI #240 Proprietary Names for New Animal Drugs
Guidance DocumentJune 1, 2020Center for Veterinary Medicine
CVM GFI #242 In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products
Guidance DocumentNovember 27, 2020Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.